World Clinical Development Outsourcing Models Analysis Report 2021: Data to Compare Outsourcing Practices and Models Against Industry Peers
Dublin, April 26, 2021 (GLOBE NEWSWIRE) -- The "Clinical Development Outsourcing Models (4th Edition)" report has been added to ResearchAndMarkets.com's offering.
Trial needs and available resources often direct clinical development activities. Various outsourcing models are available to companies that have trials to conduct and limited or nonexistent in-house resources.
In addition to outsourcing dynamics and new user data regarding hybrid trials, readers will learn model utilization rates overall and by company size, reasons for use, benefits and drawbacks experienced, whether performance expectations were met, and what would prompt a change in outsourcing models. Such comparisons will better inform related outsourcing decisions.
This report takes an in-depth look at seven different clinical development outsourcing models and associated user experiences, based on respondents actively involved in their companies' outsourcing activities:
Preferred Provider
Fee-For-Service
Functional Service Provider (FSP)
Hybrid Full-Service and FSP
In-Sourced
Compound or Program-Based
Sole-Source
What You Will Learn:
Sponsors:
Use the data to compare outsourcing practices and models against industry peers
Explore which models are performing better than others
Learn advantages and disadvantages to each model
Learn why peers have chosen the models they have
Service Providers:
Stay on top of the various outsourcing models and sponsor usage
Learn the reasons for model selection and where they break down
Ensure marketing messages are designed to minimize barriers and improve performance
Major Topics:
Clinical Development Outsourcing Dynamics
Model Use and Performance
Outsourcing Model Profiles
Future Trends
Study Data
Key Topics Covered:
1. Clinical Development Outsourcing Dynamics
Primary Section Takeaways
Outsourcing Cost by Function
In-House and Outsourcing Model Allocation
Preferred Provider Type by Phase
Provider Preference by Size
Influence Over Provider Selection
2. Model Use and Performance
Primary Section Takeaways
Outsourcing Models Conducting Clinical
Development Work
Model Performance Against Expectations
Outsourcing Model Performance Scores
Benefits of Model Use
Drawbacks of Model Use
Reasons to Change Models
3. Outsourcing Model Profiles
Preferred Provider Model
Fee-For-Service Model
Functional Service Provider (FSP) Model
Hybrid Full-Service and FSP Model
In-Sourced Model
Compound or Program-Based Model
Sole-Source Model
4. Future Trends
Primary Section Takeaways
Likelihood to Deviate from Current Model
Likelihood to Change Providers Based on Trends
Hybrid Trial Plans
Current vs Future Hybrid Trials
Experiences Running Hybrid Trials
Downsides to Hybrid Trials
5. Study Data
Approaches Used
Awareness of Outsourcing Models
CRO and Sponsor Organization Preference
Compound or Program-Based Outsourcing
Current Hybrid Trials
Current Level of Outsourcing
Current Outsourcing Practices
Department-Based FSP
Downsides to Hybrid Trials
Drawbacks of Use
Fee-For-Service Outsourcing
Frequency of Use
Functional Service Provider (FSP) Outsourcing
Future Hybrid Trials
Future Trends
Geography-Based FSP
Hybrid Full Service and FSP Outsourcing
Hybrid Trials - What Has Been Frustrating
Hybrid Trials - What Has Worked Well
Impression of Hybrid Trials
In-Sourced Staff
Influence on Service Provider Selection
Likelihood to Change Providers Based on Trends
Likelihood to Deviate from Current Model
Location of Personnel
Number in Use
Outsource Model Compatibility
Outsourcing Cost Breakdown by Function
Outsourcing and In-house Model Allocation
Performance Against Expectations
Phase II/III Development Alignment
Phase-Based FSP
Preferred Provider Outsourcing
Proportions by Function
Provider Type Preference - Phase I/II
Provider Type Preference - Phase III/IV
Provider Type for Hybrid Trials
Reasons for Not Using Hybrid Trials
Reasons for Using Model
Reasons to Change Outsourcing Models - Respondent Comments
SOP and Technology Use
Selection Frequency
Sole-Source Outsourcing
Therapeutic Area-Based FSP
Use of Hybrid Trials
Use of Service Provider Type - Phase I/II
Use of Service Provider Type - Phase III/IV
Variations Used
6. Demographics
Company Type
Job Level
Primary Area of Responsibility
Clinical Study Responsibility
Knowledge of Outsourcing Models
Office Location
For more information about this report visit https://www.researchandmarkets.com/r/bt4mcz
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900